Zhejiang, China

Qiaomei Wu

This inventor holds 1 USPTO granted patent. Top assignees: Alfred E. Tiefenbacher Gmbh & Co. Kg, Zhejiang Huahai Pharmaceutical Co., Ltd.. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Qiaomei Wu. Retrieved from https://idiyas.com/inventor/qiaomei-wu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Mind of Qiaomei Wu: A Pioneer in Pharmaceutical Patents

Introduction: Qiaomei Wu, a talented inventor based in Zhejiang, China, has made significant contributions to the pharmaceutical industry. With a background that showcases his expertise and dedication, he holds one notable patent that addresses important advancements in drug formulation.

Latest Patents: Wu's patent focuses on "Candesartan cilexetil-containing granules," which include a sugar alcohol and a binder, produced through granulation with an alcoholic granulating liquid. This innovative formulation is specifically designed to stabilize candesartan cilexetil against decomposition, making it suitable for tablet production.

Career Highlights: Over the years, Qiaomei Wu has built a strong foundation in the pharmaceutical sector. He has worked with prominent companies such as Zhejiang Huahai Pharmaceutical Co., Ltd. and Alfred E. Tiefenbacher GmbH & Co. Kg., contributing to various projects that enhance drug efficacy and stability.

Collaborations: Throughout his career, Wu has collaborated with notable colleagues, including Huiyan Gao and Hao Chen. These partnerships have fostered an environment of innovation, allowing for shared insights and advancements in pharmaceutical research and development.

Conclusion: Qiaomei Wu represents the spirit of innovation in the realm of pharmaceutical inventions. With his unique patent and collaborative efforts, he continues to pave the way for advancements that benefit the industry and patients alike. His work serves as an inspiration for emerging inventors and professionals seeking to leave a mark in the world of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…